Elevated serum levels of soluble interleukin‐2 receptor in patients with Wegener's granulomatosis. Association with disease activity

Wilhelm H. Schmitt*, Christoph Heesen, ELENA Csernok, Annegret Rautmann, Wolfgang L. Gross

*Corresponding author for this work
129 Citations (Scopus)

Abstract

Objective. To investigate whether soluble interleukin‐2 receptor (sIL‐2R), a marker of T cell activation, could be a useful marker of disease activity in Wegener's granulomatosis (WG). Methods. Soluble IL‐2R levels were determined by enzyme‐linked immunosorbent assay. WG disease activity in 102 patients was assessed according to clinical features and levels of classic antineutrophil cytoplasmic antibody (c‐ANCA) and C‐reactive protein (CRP). Results. Soluble IL‐2R levels were higher in patients with generalized and active disease than in those with limited and inactive disease. In 25 patients with complete clinical remission, sIL‐2R levels were significantly elevated, although levels of CRP and c‐ANCA were normal. Eight of these 25 patients had disease relapses within 6 months. Levels of sIL‐2R were significantly higher in patients who had relapses than in those who did not. Patients with clinically active WG but low c‐ANCA or CRP levels had elevated levels of sIL‐2R. Conclusion. Levels of sIL‐2R correlate with disease activity in patients with WG, and may indicate imminent relapse.

Original languageEnglish
JournalArthritis & Rheumatism
Volume35
Issue number9
Pages (from-to)1088-1096
Number of pages9
ISSN0004-3591
DOIs
Publication statusPublished - 09.1992

Research Areas and Centers

  • Academic Focus: Center for Infection and Inflammation Research (ZIEL)

Fingerprint

Dive into the research topics of 'Elevated serum levels of soluble interleukin‐2 receptor in patients with Wegener's granulomatosis. Association with disease activity'. Together they form a unique fingerprint.

Cite this